Carbomer 910
As of the edition of 20 October 2026, Carbomer 910 is a small molecule: marketed, first approved in 1987 (CH).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1995
- Kind
- Small molecule
- Brand name
- Viscotears
- First approved
- 24 March 1987 (CH)
- Approvals on record
- 4 in 2 regions
- Holder of the most recent approval
- Thea Pharma; 3 holders in all
- Registered trials
- 10, 1 stopped early
- Disease areas
- Eye; Immune system; Infections; Mouth and teeth; Bones, joints and muscles; Lungs and airways
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 5 | 2 | 0 | 0 |
| Phase 1 | 2 | 1 | 0 | 1 |
| Phase 2 | 2 | 1 | 0 | 0 |
| Phase 4 | 1 | 1 | 0 | 0 |
| All trials | 10 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Thea Pharma | Applicant | 1998 to now |